CONFERENCE

July 7, 2021

InSysBio announces its participation in AAIC 2021 (Online). Alzheimer's Association International Conference is held in Denver, USA and Online in July 26-30, 2021. InSysBio Neurodegeneration Diseases team presents two posters within its frames

Read more about InSysBio to present its posters at AAIC 2021

InSysBio to take part in SMB 2021

May 25, 2021

InSysBio announces its participation in Society of Mathematical Biology Annual Meeting (SMB 2021) which is to be held virtually this year June 13-17, 2021. InSysBio team is going to present 4 posters and Oleg Demin Jr is going to give a presentation "Implementation of variability or uncertainty in parameter values to validate QSP models." and Ivan Borisov is going to give a talk "Constrained Optimization Approach to Predictability Analysis in Bio-Mathematical Modeling."

Read more about InSysBio to take part in SMB 2021

InSysBio to take part in ACoP11

September 16, 2020

InSysBio announces its participation in Eleventh American Conference on Pharmacometrics (ACoP11) which is to be held in virtual format this year due to COVID-19 spread 9-13 November, 2020. The theme of ACoP11 is “Scaling New Heights.” InSysBio team is going to present 9 posters in frames of the Conference

Read more about InSysBio to take part in ACoP11

InSysBio to present its posters at AAIC 2020 Virtual Event

July 27, 2020

InSysBio announces its participation in AAIC 2020 Virtual Event. Alzheimer's Association International Conference is held virtually on July 27-31. InSysBio team presents two posters within its frames

Read more about InSysBio to present its posters at AAIC 2020 Virtual Event

InSysBio team posters to be presented at AACR Virtual Annual Meeting II

PUBLICATION

June 22, 2020

AACR Virtual Annual Meeting II has begun! American Association for Cancer Research Annual Meeting is held virtually this year on June 22-24 due to COVID-19 spread. Today InSysBio team's posters were published on AACR website

Read more about InSysBio team posters to be presented at AACR Virtual Annual Meeting II

InSysBio to take part in AACR Virtual Annual Meeting II

May 15, 2020

InSysBio announces its participation in AACR Virtual Annual Meeting II June 22-24, American Association for Cancer Research Annual Meeting which is held virtually this year due to COVID-19 spread. Today InSysBio team's abstracts were published on AACR website

Read more about InSysBio to take part in AACR Virtual Annual Meeting II

InSysBio to share the news from QSPC2020 management

March 10, 2020

Today we have received the concerning news from QSPC2020 organizers about the cancellation of the conference in response to COVID-19 outbreak continuation. Quantitative Systems Pharmacology Conference 2020 was planned to be held in April 22-24, 2020 Leiden, The Netherlands. InSysBio team was prepared to present 10 posters

Read more about InSysBio to share the news from QSPC2020 management

13th InSysBio Annual Internal Scientific Meeting

March 3, 2020

26-28 February 2020 InSysBio QSP-company held its 13th Annual Internal Scientific Meeting. InSysBio team presented the results of 2019 year professional progress. Every member demonstrated their personal achievements and shared the plans for the future development. Oleg Demin, InSysBio CEO and founder, summarized all the company’s advancement of the year 2019.

Read more about 13th InSysBio Annual Internal Scientific Meeting

InSysBio to participate in ASCPT 2020

February 19, 2020

InSysBio announced its participation in 121st Annual meeting of American Society for Clinical Pharmacology and Therapeutics (ASCPT 2020) which is to be held on March 18-21, 2020 at Marriott Marquis Houston, TX. InSysBio welcomes visitors at the booth # 102. Oleg Demin, CEO of InSysBio, Tatiana Karelina, lead modeler in Alzheimer's Disease and Veronika Musatova, Head of IRT development team, will present the new version of IRT (Immune Response Template) and Cytocon DB (Cell and cYTOkine CONcentrations).

Read more about InSysBio to participate in ASCPT 2020

InSysBio QSP model for BTK inhibitors will be presented at the 61 ASH Annual Meeting

December 3, 2019

QSP model of BTK inhibitors developed by InSysBio in collaboration with BeiGene will be presented as a poster by Srikumar Sahasranaman from Beigene at 61st American Society of Hematology (ASH) Annual Meeting & Exposition. The model describes marketed BTK inhibitors (ibrutinib and acalabrutinib) and zanubrutinib, a BTK inhibitor which recently received accelerated approval from the FDA as a treatment for mantle cell lymphoma (MCL) in adult patients who have received at least one prior therapy.